140 related articles for article (PubMed ID: 4055050)
21. Respiratory superinfections after the use of third-generation cephem antibiotics.
Saito A; Mori K; Shigeno Y; Yamaguchi K; Hara K
Infection; 1985; 13 Suppl 1():S89-95. PubMed ID: 4055061
[TBL] [Abstract][Full Text] [Related]
22. Bone and joint infections caused by gram-positive bacteria: treatment with cefotaxime.
LeFrock J; Mader J; Smith B; Carr B
Infection; 1985; 13 Suppl 1():S50-5. PubMed ID: 4055056
[TBL] [Abstract][Full Text] [Related]
23. [Ceftizoxime in the treatment of infective pathology in the elderly].
Garotta F; Magni O; Meinardi G
Boll Chim Farm; 1986 Dec; 125(12):127S-131S. PubMed ID: 3473994
[No Abstract] [Full Text] [Related]
24. Comparative clinical evaluation of imipenem/cilastatin vs. cefotaxime in treatment of severe bacterial infections.
Stamboulian D; Argüello EA; Jasovich A; Villar O; Maglio F
Rev Infect Dis; 1985; 7 Suppl 3():S458-62. PubMed ID: 3901208
[TBL] [Abstract][Full Text] [Related]
25. Clinical experience with cefotaxime for the therapy of bacteremias due to gram-positive organisms.
Schleupner CJ
Infection; 1985; 13 Suppl 1():S28-33. PubMed ID: 4055051
[TBL] [Abstract][Full Text] [Related]
26. Cephalosporins--cefotaxime 10 years later, a major drug with continued use.
Neu HC
Infection; 1991; 19 Suppl 6():S309-15. PubMed ID: 1791075
[TBL] [Abstract][Full Text] [Related]
27. Ceftriaxone therapy of serious bacterial infections.
Eron LJ; Park CH; Goldenberg RI; Poretz DM
J Antimicrob Chemother; 1983 Jul; 12(1):65-78. PubMed ID: 6311783
[TBL] [Abstract][Full Text] [Related]
28. The efficacy of cefotaxime in gram-positive surgical infections.
Wittmann DH; Frommelt L
Infection; 1985; 13 Suppl 1():S37-42. PubMed ID: 4055054
[TBL] [Abstract][Full Text] [Related]
29. [Effectiveness and tolerance of cefixime in bacterial infections in the ENT area].
Theopold M; Benner U; Bauernfeind A
Infection; 1990; 18 Suppl 3():S122-4. PubMed ID: 2079370
[TBL] [Abstract][Full Text] [Related]
30. Clinical efficacy of cefotaxime in serious infections.
Karakusis PH; Feczko JM; Goodman LJ; Hanlon DM; Harris AA; Levin S; Trenholme GM
Antimicrob Agents Chemother; 1982 Jan; 21(1):119-24. PubMed ID: 6282202
[TBL] [Abstract][Full Text] [Related]
31. [Laboratory and clinical investigations of cefodizime in infectious diseases in childhood].
Komada Y; Arai S; Kamiya H; Sakurai M; Shimizu S; Nishi H; Inoue M; Kojima M; Kawaguchi H; Yoshizumi T
Jpn J Antibiot; 1989 Jun; 42(6):1346-57. PubMed ID: 2795858
[TBL] [Abstract][Full Text] [Related]
32. Gram-positive superinfections following beta-lactam chemotherapy: the significance of the enterococcus.
Jones RN
Infection; 1985; 13 Suppl 1():S81-8. PubMed ID: 3902652
[TBL] [Abstract][Full Text] [Related]
33. The use of cefotaxime in the treatment of gram-positive pneumonias.
Jenkinson SG
Infection; 1985; 13 Suppl 1():S14-7. PubMed ID: 4055045
[TBL] [Abstract][Full Text] [Related]
34. Cefotiam therapy of lower respiratory tract infections.
Polis MA; Tuazon CU
Antimicrob Agents Chemother; 1985 Oct; 28(4):576-7. PubMed ID: 3865632
[TBL] [Abstract][Full Text] [Related]
35. [Review [New antibiotics series VI]: Ceftizoxime (author's transl)].
Shimizu K; Shimada J
Jpn J Antibiot; 1982 Apr; 35(4):869-83. PubMed ID: 6285027
[No Abstract] [Full Text] [Related]
36. Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections.
Beumer HM
Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):30-3. PubMed ID: 2663735
[TBL] [Abstract][Full Text] [Related]
37. [Clinical evaluation of cefotiam in internal medicine].
Kawamura S; Sakata Y; Chiba Y; Yoshida Y; Aizawa M; Nara H; Yanagiya S; Fukushi K; Ohmi T; Okamoto K; Komatsu Y; Haneda Y; Tanabe K; Segawa M; Yamagata A; Kawatsu S
Jpn J Antibiot; 1982 May; 35(5):1136-44. PubMed ID: 6290697
[TBL] [Abstract][Full Text] [Related]
38. Cefepime versus cefotaxime in the treatment of lower respiratory tract infections.
Barckow D; Schwigon CD
J Antimicrob Chemother; 1993 Nov; 32 Suppl B():187-93. PubMed ID: 8150762
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic efficacy and tolerability of cefotaxime--a study of acute respiratory infections in chronic lung conditions.
Shah SP; Mehta AP; Shetty SR; Mahashur AA; Kamat SR
J Postgrad Med; 1988 Jan; 34(1):15-20. PubMed ID: 3385652
[No Abstract] [Full Text] [Related]
40. [Clinical studies of cefotaxime in infections in internal medicine].
Kawasaki H; Suou T; Watanabe K; Yoshida K; Sasaki H; Kishimoto Y; Sugihara T; Ishitobi S; Kanno S; Tsuruhara I
Jpn J Antibiot; 1984 Sep; 37(9):1714-28. PubMed ID: 6096586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
